Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1697711rdf:typepubmed:Citationlld:pubmed
pubmed-article:1697711lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1697711lifeskim:mentionsumls-concept:C1522721lld:lifeskim
pubmed-article:1697711lifeskim:mentionsumls-concept:C0333977lld:lifeskim
pubmed-article:1697711lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:1697711pubmed:issue3lld:pubmed
pubmed-article:1697711pubmed:dateCreated1990-10-9lld:pubmed
pubmed-article:1697711pubmed:abstractTextIn an effort to better distinguish the morphologic relationship of atypical hyperplasia of the prostate to benign prostatic hypertrophy and prostatic cancer, 43 prostate specimens were analyzed with ten immunohistologic markers. Two cytokeratin antibodies appeared useful (Cyto M and Cyto P, with the latter slightly more discriminatory). In summary, it appears that atypical hyperplasia is immunohistopathologically related to both benign prostatic hypertrophy and prostatic cancer, having characteristics of both.lld:pubmed
pubmed-article:1697711pubmed:languageenglld:pubmed
pubmed-article:1697711pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1697711pubmed:citationSubsetIMlld:pubmed
pubmed-article:1697711pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1697711pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1697711pubmed:statusMEDLINElld:pubmed
pubmed-article:1697711pubmed:issn0300-5623lld:pubmed
pubmed-article:1697711pubmed:authorpubmed-author:ShawMMlld:pubmed
pubmed-article:1697711pubmed:authorpubmed-author:GuinanPPlld:pubmed
pubmed-article:1697711pubmed:authorpubmed-author:RubensteinMMlld:pubmed
pubmed-article:1697711pubmed:authorpubmed-author:ChorSSlld:pubmed
pubmed-article:1697711pubmed:authorpubmed-author:RauZZlld:pubmed
pubmed-article:1697711pubmed:issnTypePrintlld:pubmed
pubmed-article:1697711pubmed:volume18lld:pubmed
pubmed-article:1697711pubmed:ownerNLMlld:pubmed
pubmed-article:1697711pubmed:authorsCompleteYlld:pubmed
pubmed-article:1697711pubmed:pagination193-6lld:pubmed
pubmed-article:1697711pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1697711pubmed:meshHeadingpubmed-meshheading:1697711-...lld:pubmed
pubmed-article:1697711pubmed:meshHeadingpubmed-meshheading:1697711-...lld:pubmed
pubmed-article:1697711pubmed:meshHeadingpubmed-meshheading:1697711-...lld:pubmed
pubmed-article:1697711pubmed:meshHeadingpubmed-meshheading:1697711-...lld:pubmed
pubmed-article:1697711pubmed:meshHeadingpubmed-meshheading:1697711-...lld:pubmed
pubmed-article:1697711pubmed:meshHeadingpubmed-meshheading:1697711-...lld:pubmed
pubmed-article:1697711pubmed:meshHeadingpubmed-meshheading:1697711-...lld:pubmed
pubmed-article:1697711pubmed:meshHeadingpubmed-meshheading:1697711-...lld:pubmed
pubmed-article:1697711pubmed:meshHeadingpubmed-meshheading:1697711-...lld:pubmed
pubmed-article:1697711pubmed:year1990lld:pubmed
pubmed-article:1697711pubmed:articleTitleAn immunohistologic characterization of human prostatic atypical hyperplasia.lld:pubmed
pubmed-article:1697711pubmed:affiliationHektoen Institute for Medical Research, Chicago, Illinois.lld:pubmed
pubmed-article:1697711pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1697711pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1697711lld:pubmed